https://european-biotechnology.net/wp-content/uploads/2025/10/Fund_561407813_gxBImUPADGeLd76der57q0VC45cPhSd5-e1761660902697.jpg370967Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-28 07:59:402025-10-28 07:59:40GHO Capital expands healthcare reach with €2.5bn Fund IV close
https://european-biotechnology.net/wp-content/uploads/2025/10/Hemab_1760407451_tg-e1761576825745.jpg535957Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-27 14:53:532025-10-27 14:53:53Hemab Therapeutics bags US$157m in Series C financing
https://european-biotechnology.net/wp-content/uploads/2025/10/Electra-CD47_PDB_2JJS-e1761139055624-1030x580-1.png5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-22 13:23:152025-10-22 13:23:15Electra Therapeutics raises US$183m in Series C financing
https://european-biotechnology.net/wp-content/uploads/2025/10/ESMO-e1761055975736-1030x581-1.jpg5811030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-21 14:13:192025-10-21 14:13:19Tubulis presents first clinical data on ADC TUB-040
